EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
   3.4.21.B12 | Leukoencephalopathies |
32101834 |
A Case of Cerebral Small Vessel Disease Related to a Heterozygous Nonsense Mutation in HTRA1. |
causal interaction
unassigned |
3
0 |
| 3.4.21.B12 | Neoplasm Metastasis |
34373558 |
A KLK4 proteinase substrate capture approach to antagonize PAR1. |
causal interaction
unassigned |
3
0 |
| 3.4.21.B12 | Neoplasms |
34373558 |
A KLK4 proteinase substrate capture approach to antagonize PAR1. |
causal interaction
unassigned |
3
0 |
| 3.4.21.B12 | Neoplasms |
28454262 |
Aberrant KLK4 gene promoter hypomethylation in pediatric hepatoblastomas. |
therapeutic application
unassigned |
1
0 |
| 3.4.21.B12 | Neoplasms |
30811511 |
Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
4
1 |
| 3.4.21.B12 | Ovarian Neoplasms |
30811511 |
Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
4
1 |
| 3.4.21.B12 | Mouth Neoplasms |
25862839 |
Clinical significance of kallikrein-related peptidase-4 in oral cancer. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
2
4
0 |
| 3.4.21.B12 | Neoplasms |
21912076 |
Comparative Temporospatial Expression Profiling of Murine Amelotin Protein during Amelogenesis. |
unassigned |
0 |
| 3.4.21.B12 | Prostatic Neoplasms |
16322328 |
Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms. |
causal interaction
diagnostic usage
unassigned |
3
4
0 |
| 3.4.21.B12 | Prostatic Neoplasms |
31397325 |
Crystal structure of the inhibitor-free form of the serine protease kallikrein-4. |
causal interaction
diagnostic usage
unassigned |
4
2
0 |
